多重耐药菌医院感染现状与防控研究进展

Progress in the status and prevention and control of nosocomial infection with multi-drug resistant bacteria

ES评分 3.6

DOI 10.12208/j.ijnr.20240050
刊名
International Journal of Nursing Research
年,卷(期) 2024, 6(2)
作者
作者单位

南方医科大学第十附属医院东莞市人民医院 广东东莞 ;

摘要
临床应用的第一种抗生素是青霉素,其具有较强的抗金黄色葡萄球菌作用。从20世纪40年代,青霉素用于临床开始,临床对抗菌药物加大了研究和开发力度,临床治疗各种疾病中都广泛地使用各种新型抗菌药物,虽然这些药物降低了感染性疾病(肺炎、肺结核等)患者的死亡率,但是由于临床普遍存在滥用抗菌药物的问题,导致一些致病菌对一部分抗菌药物生成耐药性,且生成多种多重耐药菌(Multi-drug resistant bacteria,MDRO),其中耐甲氧西林金黄色葡萄球菌是临床最早发现的MDRO。MDRO是院感爆发的主要原因,一旦感染MDRO,会显著增加治疗难度,提高患者死亡率。因此深入研究MDRO导致院感现状、防控措施,具有重大临床价值。
Abstract
The first antibiotic in clinical application is penicillin, which has a strong anti-staphylococcus aureus effect. Since the 1940s, when penicillin was used in clinic, clinical research and development of antibacterial drugs have been intensified, and various new antibacterial drugs are widely used in clinical treatment of various diseases. Although these drugs have reduced the mortality rate of patients with infectious diseases (pneumonia, tuberculosis, etc.), there is a widespread problem of abuse of antibacterial drugs. As a result, some pathogenic bacteria become resistant to some antimicrobial drugs, and a variety of Multi-drug resistant bacteria (MDRO) are generated, of which methicillin-resistant Staphylococcus aureus is the earliest MDRO found in the clinic. MDRO is the main cause of hospitalization outbreak, once infected with MDRO, it will significantly increase the difficulty of treatment and increase the mortality of patients. Therefore, it is of great clinical value to study the status quo and prevention and control measures of hospital feeling caused by MDRO.
关键词
多重耐药菌;医院感染;防控措施
KeyWord
Multi-drug resistant bacteria; Hospital infection; Prevention and control measures
基金项目
页码 71-73
  • 参考文献
  • 相关文献
  • 引用本文

梁金凤*,邓勇进,赵妙玲,杜丽华. 多重耐药菌医院感染现状与防控研究进展 [J]. 国际护理学研究. 2024; 6; (2). 71 - 73.

  • 文献评论

王**宁夏医科****** 已认证✔

2026-01-20 10:07:29

全文泛泛而谈,应增加医院感染多重耐药菌的种类、感染率等数据

相关学者

相关机构